Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma
暂无分享,去创建一个
R. Houot | M. Kersten | V. Plaks | U. Dührsen | J. Kuruvilla | P. Lugtenburg | J. Rossi | I. Avivi | A. Bot | A. Kerber | S. Vardhanabhuti | M. Wermke | M. Minnema | C. Thieblemont | Jenny J. Kim | M. Topp | K. Song | T. van Meerten | K. Bouabdallah | M. Sherman | Yan Zheng | Jinghui Dong